Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss

Clinical trial NCT06029673 · COMPLETED

Trial details

NCT number: NCT06029673
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lactation Suppressed

Start date: 2024-02-07
Primary completion: 2025-06-15
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.